FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation

Journal of Surgical Research

Volumn 97, Issue 2, 2001, Pages 123-130

  Shah, Shimul A ^a   Potter, Michael W ^a   Ricciardi, Rocco ^a   Perugini, Richard A ^a   Callery, Mark P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cdc2; Cell cycle; P70s6 kinase; Pancreatic cancer; PI 3 kinase; Rapamycin

Indexed keywords

CELL CYCLE PROTEIN; FRAP KINASE; P70S6 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; RAPAMYCIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0035746918     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6145     Document Type: Article

References (25)

1. The molecular and cellular biology of pancreatic cancer
2. p21ras: An oncoprotein functioning in growth factor-induced signal transduction
3. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
4. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas
5. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α
6. The role of p21ras in receptor tyrosine kinase signalling
7. Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent
8. s6K
9. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases
10. The 70 kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signalling
11. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression
12. Control of p70 s6 kinase by kinase activity of FRAP in vivo
13. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
14. s6K pathway and independent of mitogen-activated protein kinase
15. s6K pathway in human pancreatic cancer cells
16. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS 1 in pancreatic tumors
17. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
18. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
19. Activation of Raf-1 in human pancreatic adenocarcinoma
20. Rapamycins: Antifungal, anti-tumor, anti-proliferative and immunosuppressive molecules
21. Rapamycin, a potent immunosuppressive drug, causes programmed cell death in a B lymphoma cells
22. Rapamycin inhibits constitutive p70s6K phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells
23. The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin
24. Induction of the mitogen-activated p70S6 kinase by adenovirus E1A
25. Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies radiation-induced G2-phase arrest in HeLa cells